Your browser doesn't support javascript.
loading
Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.
Horimoto, Y; Arakawa, A; Harada-Shoji, N; Sonoue, H; Yoshida, Y; Himuro, T; Igari, F; Tokuda, E; Mamat, O; Tanabe, M; Hino, O; Saito, M.
Affiliation
  • Horimoto Y; 1] Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan [2] Department of Pathology and Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Arakawa A; Department of Human Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Harada-Shoji N; Division of Cancer, Department of Surgery and Cancer, 1st Floor, ICTEM Building, Hammersmith Hospital, Imperial College London, London W12 0NN, UK.
  • Sonoue H; Department of Human Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Yoshida Y; Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Himuro T; Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Igari F; Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Tokuda E; Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Mamat O; Department of Human Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Tanabe M; Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Hino O; Department of Pathology and Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Saito M; Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Br J Cancer ; 112(2): 345-51, 2015 Jan 20.
Article in En | MEDLINE | ID: mdl-25422910
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Gene Expression / Carcinoma, Ductal, Breast / Hepatocyte Nuclear Factor 3-alpha Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Br J Cancer Year: 2015 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Gene Expression / Carcinoma, Ductal, Breast / Hepatocyte Nuclear Factor 3-alpha Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Br J Cancer Year: 2015 Type: Article Affiliation country: Japan